Biomarkers of Potential Harm among Adult Cigarette and Smokeless Tobacco Users in the PATH Study Wave 1 (2013–2014): A Cross-sectional Analysis-Reference-Cited by-同舟云学术

Biomarkers of Potential Harm among Adult Cigarette and Smokeless Tobacco Users in the PATH Study Wave 1 (2013–2014): A Cross-sectional Analysis

Published:2021-05-04 Issue:7 Volume:30 Page:1320-1327
ISSN:1055-9965
Container-title:Cancer Epidemiology Biomarkers & Prevention
language:en
Short-container-title:Cancer Epidemiol Biomarkers Prev

Author:

Chang Joanne T.,Vivar Juan C.^ORCID,Tam Jamie^ORCID,Hammad Hoda T.^ORCID,Christensen Carol H.,van Bemmel Dana M.,Das Babita,Danilenko Uliana,Chang Cindy M.^ORCID

Funder

National Institute on Drug Abuse

Center for Tobacco Products

Food and Drug Administration

Department of Health and Human Services

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology,Epidemiology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimating lung cancer risk from e-cigarettes and heated tobacco products based on biomarkers of exposure and of potential harm (a) Methodology and examples;2024-07-29

2. Assessing the Relationship between Biomarkers of Exposure and Biomarkers of Potential Harm: PATH Study Wave 1 (2013 to 2014);Cancer Epidemiology, Biomarkers & Prevention;2024-06-11

3. Harm perceptions across vaping product features: An on‐line cross‐sectional survey of adults who smoke and/or vape in the United Kingdom;Addiction;2024-06-05

4. Use of Traditional Smokeless, Snus, and Dissolvable Tobacco Among U.S. Youth;American Journal of Preventive Medicine;2023-02

5. Dietary Antioxidants and Lung Cancer Risk in Smokers and Non-Smokers;Healthcare;2022-12-10